Glycopeptides antibiotics of dalbaheptide group
(vancomycin and teicoplanin) are the drugs of choice for the treatment of infections due to multi-resistant Grampositive bacteria. The current project on new semisynthetic glycopeptides aim at pursuing activity against highly glycopeptide-resistant (VanA) enterococci and at improving the eficacies of these antibiotics against methicillin-resistant and coagulase-negative staphylococci, while maintaining excellent activity against other glycopeptide-susceptible Gram-positive pathogens.
In the last few years, chemical modification of glycopeptide antibiotics led to several derivatives active against both resistant and susceptible Gram-positive bacteria1,2). Derivatives of chloroeremomycin (LY 264826) with lipophilic substitutes on the sugar moiety were reported to exhibit improved activity against vancomycin-resistant enterococci as well as other Grampositive bacteria2). Recently we have described the synthesis of aminomethylated derivatives of eremomycin at the 7d position of the resorcinol ring of the amino acid No. 73). Among these derivatives, 7d-n-decylaminomethyl eremomycin was the most potent against both resistant and susceptible bacteria.
In this paper we report the synthesis and in vitro antibacterial activities of 7d-aminomethylated derivatives of teicoplanin aglycon (TD) and their amides ( Fig .  1 ) with substituents similar to those, which had previously been shown to effectively influence efficacy in the chloroeremomycin and eremomycin series.
Chemistry
Amnnomethylated derivatives of TD (I-XV) ( Fig . 1) were prepared by the treatment of TD or N-Boc-TD (TD protected with Boc group at the N-terminal) with a three-fold excess of the appropriate amine and a two-fold excess of aqueous formaldehyde in water -organic solvent 1:1 mixture in conditions similar to those described for eremomycin3). Similar to eremomycin, aminomethylation of TD or N-Boc-TD selectively produced 7d- protection of 7d-aminomethyl group (N'). The amidation was performed with the use of PyBOP (benzotriazolyloxy-tris-pyrrolidinophosphonium-hexafluorophosphate) as a condensing agent, which led to the corresponding Amide XX represents an exception as it was obtained from N-Boc-IV through an additional step of protection of the 7d-decylaminomethyl group (N,N'-di-Boc-IV). Activation of carboxyl group in this compound and its amidation were performed with the use of chloroacetonitrile and NH2(CH2)3NH(CH2)3NH(CH2)3NH2 as described earlier4). Yields and properties of the compounds obtained are given in Tables 1 and 2. ly elucidated by 1H NMR and MS (FAB, ESI) spectrometry.
In 1H NMR spectra all signals of TD backbone protons and the introduced substituents were identified. The chemical shifts assignment in 1H NMR spectra has been done using data obtained earlier for TD5) and amides of TD4,6). The positions of the aminomethyl substituents were determined by 1H NMR method using ROESY and HMBC experiments as previously described for eremomycin3). To a stirred solution of 1 mmol of the aminomethylated derivatives of N-Boc-TD and 1 mmol of the appropriate amine in 50 ml DMSO, was added 1.2 mmol of PyBOP.
If a salt of an amine was used, 1 mmol of TEA was added. The reaction mixture was stirred at room temperature for 4 hours and then 300ml of water was added.
The followed separation and purification were performed method 1.1 and for the compounds XXIX and XXX by the method 1.2 as described above. The deprotection was 
